Beijing Tide Pharmaceutical describes new PRMT5 inhibitors
June 5, 2025
Beijing Tide Pharmaceutical Co. Ltd. has identified protein arginine N-methyltransferase 5 (PRMT5) inhibitors reported to be useful for the treatment of cancer and myelofibrosis.